Robert Bitman

Associate

+1 858 550 6128
rbitman@cooley.com

Robert Bitman represents public and private companies in a wide range of corporate and securities matters, including entity formation, private financings, public offerings, SEC reporting and compliance, corporate governance and mergers and acquisitions.

Download full bio

Experience

  • Inhibrx – $137 Million IPO 

  • Avidity Biosciences - $289 Million IPO 

Education

  • University of San Diego School of Law
    JD, cum laude, 2019

  • University of California, Santa Barbara
    BA, Political Science
    2015


Admissions & Credentials

California

Contact

+1 858 550 6128 office
rbitman@cooley.com

4401 Eastgate Mall
San Diego, CA 92121-1909